Lindsay Woodard serves as the Principal Scientist and Supervisor of Biomaterials at Luna Labs USA, where she leverages over a decade of expertise in polymer chemistry and material characterization to innovate and develop cutting-edge medical devices and solutions. Her role is pivotal in applying structure-property...
Lindsay Woodard serves as the Principal Scientist and Supervisor of Biomaterials at Luna Labs USA, where she leverages over a decade of expertise in polymer chemistry and material characterization to innovate and develop cutting-edge medical devices and solutions. Her role is pivotal in applying structure-property relationships to create commercially viable biomaterials that meet the diverse needs of health, environmental, and military sectors. Lindsay's passion for enhancing patient quality of life drives her commitment to developing advanced materials that are not only effective but also sustainable.
At Luna Labs, Lindsay leads a variety of multidisciplinary projects that showcase her proficiency in polymer synthesis and engineering. Among her key initiatives are the development of dissolvable microneedles aimed at revolutionizing intradermal vaccine delivery, and hydrogel-based materials designed for optimal wound healing. These projects not only highlight her technical skills in differential scanning calorimetry and dynamic mechanical analysis but also underscore her ability to manage complex contracts and collaborate effectively with cross-functional teams.
Lindsay's expertise extends beyond research and development; she is adept at data analysis and polymer characterization, ensuring that each material product meets stringent industry standards. Her proficiency with tools like EndNote further enhances her ability to communicate findings and insights effectively. As a thought leader in the biomaterials field, Lindsay Woodard is dedicated to harnessing her skills to push the boundaries of polymer science, ultimately contributing to innovations that significantly improve patient outcomes and advance the medical device landscape.
